Spain: Expats Concerned About ‘Landmark’ cholesterol-lowering drug delay

0
58

Spain: Expats Concerned About 'Landmark'
cholesterol-lowering drug delay

Novartis and the NHS have reached a deal for Leqvio after NICE (the healthcare agency) approved the medication.

According to company, the drug will treat more than 300,000 people at risk for a heart attack in the next three-years.

The medicine forms part of larger campaign to combat cardiovascular disease in the UK.

Currently, around 7.6 million Brits are living with circulatory and heart diseases.

Publiated at Thu, 2 Sep 2021 15:02:05 +0000

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.